Stage IV Squamous Cell Carcinoma of the Nasopharynx Withdrawn Phase 1 Trials for Mitometh (DB12117)

IndicationStatusPhase
DBCOND0028783 (Stage IV Squamous Cell Carcinoma of the Nasopharynx)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01728480Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation TherapyTreatment